Treatment
-
Forward Look
First CAR-T Cell Therapy Approved for Multiple MyelomaCellular immunotherapies can offer periods when people do not require treatment.
by Christina Bennett
-
Forward Look
Going FlatMost people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.
by Kris Conner
-
Forward Look
What’s Next? Summer 2021Using fecal transplants to improve immunotherapy response
by Natalie Slivinski
-
Are You a Candidate for Immunotherapy?Tumor testing can help determine whether certain cancers are likely to respond to immunotherapy drugs.
by Kendall K. Morgan
-
June 18: The Week in Cancer NewsA study compares the benefits of fixed doses of immunotherapy compared to weight-based doses, and the Food and Drug Administration approves a targeted therapy for a rare disorder called systemic mastocytosis.
by Bradley Jones
-
A Treatment That Came Just in TimeCancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
-
Genetic Testing GapsTesting for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.
by Kate Yandell
-
Expanding ImmunotherapyAt a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.
by Kevin McLaughlin
-
Should All Kids With Cancer Get Genetic Testing?Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.
by Marcus A. Banks
-
Understanding How Radiation Causes CancerResearchers are investigating who is at greatest risk for radiation-induced cancers.
by Kate Yandell
